Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05889260Completed

Speech Accessibility Project

Role: collaborator

NCT04834934Completed

Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

Role: collaborator

NCT05267197Completed

3D Telemedicine: A Clinician Feedback Study

Role: collaborator

NCT03933020Not ApplicableTerminated

Impact of Physical Activity on Cognitive Outcomes in Youth With Pediatric-Onset Multiple Sclerosis (POMS)

Role: collaborator

NCT05227235Not ApplicableUnknown

Clinical Trial of 3D Telemedicine

Role: collaborator

NCT01182480Not ApplicableCompleted

Chronic Care Management/Patient Relationship Management Proof of Concept

Role: collaborator

All 6 trials loaded